Thanks to a new technology, the diagnosis of brain cancer undergoes a breakthrough. The credit goes to cancer diagnostics company and University of Strathclyde Dxcover spin-out company. The company has indeed launched the liquid biopsy Dxcover, which was also effective in the early days of cancer growth, at a smaller volume and earlier stage.
q
There Research was published in the scientific journal Cancers.
Brain cancer: here are the advantages of the Dxcover liquid biopsy
According to Cancer Research UK, a 12,000 people in Britain are diagnosed with brain cancer each year and survival rates are 12% five years after diagnosis.
Read Also
- The Legend of Zelda: Skyward Sword HD – Zelda retrospective and new trailer Jul 8, 2021
- “I’m worried about his mental health”: Maryfer Centeno analyzed Nodal’s lawsuit against J Balvin Jun 3, 2022
- 44 survivors of the “Ocean Viking” will be expelled from French territory, announces Gérald Darmanin to the Assembly Nov 16, 2022
- Genshin Impact: release date of version 2.0, trailer reveals all the details Jul 9, 2021
- They return 8 Dominicans and 15 Haitians who tried to arrive illegally in Puerto Rico May 28, 2022
- Budget: Chamber approves 3 RN indications and Marcel will reserve constitutionality Nov 16, 2022
- Finistère and Vendée: Darmanin confuses the Saint-Urbains and expresses his support for the bad mayor Nov 20, 2022